Injectafer is an injectable intravenous medication manufactured in the United States used to treat patients with Adult Iron Deficiency Anemia. It is administered in two dosages separated by at least 7 days or more.
Researchers and physicians have reported that patients injected with ferric carboxymaltose (FCM), the type of iron used in Injectafer, may not have warned patients of the risk of them getting severe Hypophosphatemia (HPP). HPP is an abnormally low level of phosphate in a person’s blood. Severe HPP can cause severe symptoms such as: Read more